BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15296950)

  • 41. The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity.
    Herbig ME; Assi F; Textor M; Merkle HP
    Biochemistry; 2006 Mar; 45(11):3598-609. PubMed ID: 16533042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
    Meade BR; Dowdy SF
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arginine-rich peptides and their internalization mechanisms.
    Futaki S; Nakase I; Tadokoro A; Takeuchi T; Jones AT
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):784-7. PubMed ID: 17635148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug delivery of oligonucleotides by peptides.
    Lochmann D; Jauk E; Zimmer A
    Eur J Pharm Biopharm; 2004 Sep; 58(2):237-51. PubMed ID: 15296952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interaction of cell-penetrating peptides with lipid model systems and subsequent lipid reorganization: thermodynamic and structural characterization.
    Alves ID; Correia I; Jiao CY; Sachon E; Sagan S; Lavielle S; Tollin G; Chassaing G
    J Pept Sci; 2009 Mar; 15(3):200-9. PubMed ID: 18985709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The CPP Tat enhances eGFP cell internalization and transepithelial transport by the larval midgut of Bombyx mori (Lepidoptera, Bombycidae).
    Cermenati G; Terracciano I; Castelli I; Giordana B; Rao R; Pennacchio F; Casartelli M
    J Insect Physiol; 2011 Dec; 57(12):1689-97. PubMed ID: 21959108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the biomedical promise of cell penetrating peptides: limits versus prospects.
    Foerg C; Merkle HP
    J Pharm Sci; 2008 Jan; 97(1):144-62. PubMed ID: 17763452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects.
    Palm C; Netzereab S; Hällbrink M
    Peptides; 2006 Jul; 27(7):1710-6. PubMed ID: 16500001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in cell-penetrating, non-peptide molecular carriers.
    Chung SK; Maiti KK; Lee WS
    Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides.
    Jones AT
    Int J Pharm; 2008 Apr; 354(1-2):34-8. PubMed ID: 18068916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted intracellular delivery of therapeutics: an overview.
    Rawat A; Vaidya B; Khatri K; Goyal AK; Gupta PN; Mahor S; Paliwal R; Rai S; Vyas SP
    Pharmazie; 2007 Sep; 62(9):643-58. PubMed ID: 17944316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M; Langel U
    Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
    Wadia JS; Dowdy SF
    Adv Drug Deliv Rev; 2005 Feb; 57(4):579-96. PubMed ID: 15722165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
    Juliano RL
    Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.